Ebury Partners Markets Cyprus Limited Review

When a broker has no independent user reviews, our job is to build the picture from the ground up: the corporate registry, the regulator's public records, and the firm's own disclosures. For Ebury Partners Markets Cyprus Limited, we cross-checked the official domain (ebury.com), the Cyprus company registry, and the CySEC licence register, and we reviewed the client-facing documents the firm publishes on its own site — the Client Information Pack, the Best Interest and Order Execution Policy, and the Product and Risk Disclosure.

We found a consistent, coherent record. The entity is a Cyprus Investment Firm (CIF) authorised by CySEC under licence number 459/25, and the documents we reviewed repeatedly cite that same licence and the same incorporation number (HE 439971). That alignment between the regulator's register, the corporate documents, and the official website is exactly what we look for when separating a genuine firm from a lookalike. In FXCanary's assessment, this is a real, regulated entity — but as we explain below, being regulated does not mean being risk-free, and the absence of independent user feedback is itself a signal traders should weigh.

Ebury Partners Markets Cyprus Limited is incorporated in the Republic of Cyprus, with its registered address at DOMS Assets Business Centre, 33 Neas Engomis Street, 2409 Engomi, Nicosia. The company number HE 439971 appears in the firm's own relationship agreement, and the entity describes itself as a Cyprus Investment Firm under MiFID II as transposed into Cypriot law (Law 87(I)/2017). This is a standard corporate structure for a broker serving European clients, and the Nicosia address is consistent with a firm that intends to operate within the EU regulatory framework.

The parent brand, Ebury, is a well-known global fintech platform focused on cross-border payments, FX hedging, and business financing — the group claims 160+ countries for payments, 140+ currencies, and 50+ offices. The Cyprus entity, however, is a distinct legal person: it is the MiFID-licensed arm that offers investment services, including OTC derivative products, to clients. That separation matters. When you open an account with Ebury Partners Markets Cyprus, your counterparty is the Cypriot entity, not the global brand, and your protections flow from the Cypriot licence, not from the group's marketing footprint.

We could not verify the founding date of the Cyprus entity from our records, and the firm's own materials do not state one. The CySEC licence is dated 08/09/2025 in aggregated industry data, which suggests the entity is newly authorised. A fresh licence is not a negative in itself — every broker starts somewhere — but it does mean there is no track record of regulatory behaviour to inspect, and no history of client complaints or resolutions to learn from.

The single most important fact about this broker is that it holds a Cyprus Securities and Exchange Commission (CySEC) licence as a Cyprus Investment Firm, number 459/25, with status Authorised. We verified this against the firm's own published documents, which cite the licence number consistently, and against aggregated industry data that lists the same number. In our records, this is the only licence on file — there is no FCA authorisation, no offshore licence, and no other regulator listed.

What does a CySEC CIF licence actually mean for a client? It means the firm is subject to MiFID II conduct-of-business rules, including client money segregation, best execution obligations, and suitability assessments. It also means the firm must hold minimum regulatory capital — under the IFPR regime, a CIF must maintain a Permanent Minimum Capital Requirement (PMCR) and, depending on its activities, additional own funds. These capital rules are designed to ensure the firm can meet its obligations even in stress, though they do not guarantee that a firm will never fail.

Critically, a CySEC licence brings clients into the scope of the Investor Compensation Fund (ICF) for Cyprus, which covers eligible client claims up to €20,000 per person if the firm fails. That is a real, statutory safety net — but it is capped, and it does not cover investment losses. It only protects against the firm's insolvency or misappropriation of funds, not against market losses. In FXCanary's assessment, the presence of a CySEC licence is a significant positive: it places the firm inside a regulated, supervised framework with enforceable rules. The absence of any additional licence, however, means clients outside the EU should check whether the firm is permitted to serve them at all.

Client money segregation is the cornerstone of the CySEC regime. Under MiFID II, a CIF must keep client funds in accounts separate from its own operating accounts, typically with a third-party credit institution, and it must reconcile those accounts regularly. If the firm becomes insolvent, segregated client funds should not form part of the firm's estate — they belong to clients. In practice, segregation is only as good as the firm's operational discipline, which is why the regulator's ongoing supervision matters.

CySEC also imposes leverage limits on retail clients under ESMA's product intervention measures. For major currency pairs, the maximum leverage is 30:1; for non-major pairs, gold and major indices it is 20:1; for commodities and non-major indices it is 10:1; for individual equities and other references it is 5:1; and for cryptocurrencies it is 2:1. These caps are designed to protect retail investors from the worst excesses of leveraged trading. Professional clients can access higher leverage, but only if they meet the qualifying criteria — a point we return to later.

The compensation scheme adds another layer: the Cyprus Investor Compensation Fund covers eligible clients up to €20,000. That is a modest sum by international standards — the UK's FSCS, for example, covers £85,000 — but it is a genuine backstop. For a trader considering this broker, the practical takeaway is that their funds are segregated, their leverage is capped, and they have a statutory claim against the fund if the firm collapses. None of that protects them from losing money on a trade, but it does reduce the risk of losing money to the broker itself.

Our records do not include specific account tiers, minimum deposits, or leverage figures for Ebury Partners Markets Cyprus. The firm's own disclosures describe the products it offers — OTC derivatives, including contracts for difference (CFDs) — but they do not, in the materials we reviewed, set out a menu of account types with named tiers such as 'Standard' or 'Premium'. This is a notable gap in transparency, and we flag it plainly.

What we can infer from the regulatory framework is that the firm must apply ESMA's leverage caps to retail clients, and that it must classify clients as retail, professional, or eligible counterparty. The Client Information Pack mentions that the firm serves both retail and wholesale (professional) clients, which is consistent with a firm that offers a range of services. But without published minimums, a prospective client cannot easily compare this broker against others on cost of entry.

In FXCanary's assessment, the absence of published account-tier details is a caution flag. It does not mean the firm is hiding something — many institutional-facing firms do not advertise retail account tiers — but it does mean a trader must contact the firm directly to learn the terms. We recommend that any prospective client ask for the full account documentation, including the Product and Risk Disclosure, before depositing funds, and confirm in writing the minimum deposit, spreads, commissions, and leverage that will apply to their account.

The firm's own materials do not specify which trading platforms it offers. The Ebury group's website emphasises its business banking platform — payments, collections, mass payments, corporate cards, and API integrations — but that is a different product from the CFD trading platform that the Cyprus entity would provide. We found no reference to MetaTrader 4, MetaTrader 5, or any proprietary platform in the documents we reviewed.

This is a significant unknown. For a retail trader, the platform is the primary interface with the market — its usability, charting tools, execution speed, and reliability directly affect the trading experience. Without a named platform, we cannot assess whether the firm offers the tools that scalpers, swing traders, or algorithmic traders need. We can only note that the firm, as a CySEC-licensed CIF, is required to provide best execution and to disclose its order execution policy — which it does in a dedicated policy document.

We recommend that any trader considering this broker ask directly which platforms are supported, whether demo accounts are available, and how execution is handled (market maker, straight-through processing, or electronic communication network). The answers to those questions will determine whether the firm is a fit for the trader's style. Until those answers are public, the platform offering remains an open question in our review.

The Product and Risk Disclosure document describes the products as Over-the-Counter (OTC) derivatives, which in practice means CFDs on currencies, indices, commodities, and possibly cryptocurrencies and individual equities. The Ebury group's broader business is FX and payments, so it is reasonable to expect a strong focus on currency pairs, but the Cyprus entity's exact product list is not fully detailed in the materials we reviewed.

CFDs are leveraged products, which means both potential gains and losses are magnified. Under the CySEC regime, retail clients must receive a risk warning, and the firm must assess whether a product is appropriate for the client before offering it. The firm's Best Interest and Order Execution Policy confirms that it takes steps to act in the client's best interest when executing orders, which is a regulatory requirement rather than a marketing claim.

For a trader, the key question is whether the product range matches their needs. A firm focused on FX and payments may offer a narrower range of CFDs than a dedicated retail broker. We could not verify the full list of instruments from public records, so we advise traders to request the current product schedule before opening an account. The absence of a published instrument list is another transparency gap, though not unusual for a firm that targets business clients rather than mass retail.

Our records do not contain specific information on deposit methods, withdrawal processing times, or fee schedules for Ebury Partners Markets Cyprus. The Ebury group's business platform supports payments in 140+ currencies across 160+ countries, which suggests a robust payments infrastructure, but that is the group's corporate service, not necessarily the Cyprus entity's CFD offering.

Fees in CFD trading typically come in the form of spreads, commissions, and overnight swap charges. Without published figures, we cannot compare this broker's costs against the market. We also cannot confirm whether the firm charges for deposits or withdrawals, or what minimum withdrawal amounts apply.

In FXCanary's assessment, the lack of published fee information is a material gap. A trader who cannot see the cost structure before signing up is at a disadvantage. We strongly recommend that prospective clients obtain a written fee schedule from the firm, including all spreads, commissions, swap rates, and any administrative charges, and compare it against at least two other regulated brokers before committing funds.

Ebury Partners Markets Cyprus is, at its core, a regulated European entity with a credible parent brand. That makes it a plausible choice for a business or an institutional client that already uses Ebury's payment services and wants to add FX hedging or CFD exposure under the same roof. For such a client, the CySEC licence provides a familiar regulatory framework, and the group's global reach may offer integrated solutions that standalone brokers cannot match.

For a retail trader, the picture is more mixed. The firm is regulated, which is a genuine positive, but it is newly licensed, has no independent user reviews, and publishes little about its trading platforms, account tiers, or fees. A beginner trader, in particular, would face a steep learning curve without the community support and educational resources that established retail brokers typically offer. A scalper or high-frequency trader would need to know execution speeds and spreads, which are not disclosed. A swing trader might be less sensitive to execution minutiae but would still want to see the product list and costs.

We would caution any trader who is attracted solely by the Ebury brand to remember that the Cyprus entity is a separate legal person. The group's size and reputation do not automatically extend to the regulated subsidiary's client service or financial stability. Traders should also verify that the firm is permitted to serve their jurisdiction, since a CySEC licence does not authorise cross-border solicitation everywhere.

We score Ebury Partners Markets Cyprus at 34/100 on our Scam Risk Index, which we classify as 'Guarded'. That score reflects a genuine regulatory licence — the single most important factor in our methodology — offset by a lack of verifiable independent information. The risk flag in our records notes 'No verifiable website or social-media presence', which is a curious finding given that the firm operates under the ebury.com domain. We interpret this as meaning that the Cyprus entity itself does not maintain a separate marketing site or active social channels, which is typical for a B2B-focused subsidiary but unusual for a retail-facing broker.

The absence of independent user reviews is a double-edged sword. On one hand, it means there are no red flags — no complaints about withdrawals, no warnings about manipulation, no reports of frozen funds. On the other hand, it means there is no track record to validate the firm's claims. A newly licensed entity with no client feedback is an unknown quantity, and in the world of forex and CFD brokers, unknowns carry risk.

We found no clone or impersonator sites, which is a positive sign — it suggests the brand is not being actively spoofed, and it reduces the risk of a trader accidentally landing on a fraudulent lookalike. However, we cannot rule out the possibility that the firm's own website, ebury.com, is the only legitimate point of contact, and we urge traders to use only that domain and to verify any contact details against the CySEC register.

Before depositing a single euro with Ebury Partners Markets Cyprus, we recommend that a trader take the following steps. First, verify the licence directly on the CySEC website — search for 'Ebury Partners Markets Cyprus Limited' and confirm that the licence number 459/25 is listed as Authorised. Do not rely on the firm's own website or on third-party profiles; the regulator's register is the authoritative source.

Second, read the Client Information Pack and the Product and Risk Disclosure in full. These documents are available on the firm's own site and contain the legal terms that will govern your account. Pay particular attention to the sections on client money, leverage, and risk warnings. If anything is unclear, ask the firm for written clarification before you commit.

Third, test the firm with a small deposit before transferring significant funds. A regulated broker should not object to a modest initial deposit, and this gives you a chance to experience the account opening process, the platform, and the withdrawal procedure without exposing yourself to a large loss. Finally, keep your own records of all communications and transactions, and if you ever feel that the firm is not acting in your best interest, you have the right to complain to CySEC. The regulator's complaints process is a real avenue for redress, but it works best when you have documentation.

Ebury Partners Markets Cyprus Limited is a legitimate, CySEC-licensed investment firm, and that is not a small thing. In a market crowded with unregulated and offshore brokers, a valid European licence is a meaningful mark of credibility. The firm's association with the Ebury group adds further weight, even if the legal separation between the group and the subsidiary must be respected.

But legitimacy is not the same as suitability. The firm is newly authorised, has no independent user reviews, and discloses little about its trading conditions. For a trader who values transparency and a proven track record, this broker currently offers more questions than answers. We would not discourage a cautious trader from considering it, but we would insist on due diligence: verify the licence, read the documents, ask the hard questions, and start small.

In FXCanary's assessment, the 34/100 'Guarded' score is appropriate. The regulatory foundation is solid, but the lack of verifiable operational history means the risk is not negligible. As the firm builds a track record — and as independent reviews begin to appear — we will revisit our assessment. For now, the prudent path is to treat Ebury Partners Markets Cyprus as a regulated but unproven counterparty, and to act accordingly.